Literature DB >> 1584207

Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.

W B Weglicki1, T M Phillips, A M Freedman, M M Cassidy, B F Dickens.   

Abstract

We have developed two rodent models of diet-induced magnesium-deficiency in which histologically defined cardiac lesions can be induced within two to three weeks. During the development of these lesions, the magnesium-deficient animals exhibit circulating cytokine levels which are indicative of a generalized inflammatory state. Dramatic elevations of the macrophage-derived cytokines, IL-1, IL-6, and TNF-alpha together with significantly elevated levels of the endothelial cell-derived cytokine, endothelin, were detected in the plasma of these animals. We believe that the pathophysiological effects caused by the action of these cytokines may play a role in the promotion of cardiovascular pathology associated with magnesium deficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584207     DOI: 10.1007/bf02454195

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

1.  Endothelin in myocardial infarction.

Authors:  T Watanabe; N Suzuki; N Shimamoto; M Fujino; A Imada
Journal:  Nature       Date:  1990-03-08       Impact factor: 49.962

Review 2.  Cytokines in disease.

Authors:  J T Whicher; S W Evans
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

Review 3.  Magnesium deficiency cardiomyopathy.

Authors:  S Bloom
Journal:  Am J Cardiovasc Pathol       Date:  1988

4.  Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  Magnesium deficiency-induced cardiomyopathy: protection by vitamin E.

Authors:  A M Freedman; A H Atrakchi; M M Cassidy; W B Weglicki
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

6.  Increased endothelin in experimental heart failure.

Authors:  K B Margulies; F L Hildebrand; A Lerman; M A Perrella; J C Burnett
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

7.  Endothelin in experimental congestive heart failure in the anesthetized dog.

Authors:  P G Cavero; W L Miller; D M Heublein; K B Margulies; J C Burnett
Journal:  Am J Physiol       Date:  1990-08

8.  Systemic hemodynamic effects of endothelin in rats.

Authors:  A J King; J M Pfeffer; M A Pfeffer; B M Brenner
Journal:  Am J Physiol       Date:  1990-03

9.  Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock.

Authors:  P Cernacek; D J Stewart
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

Review 10.  Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion.

Authors:  M Seelig
Journal:  Am J Cardiol       Date:  1989-04-18       Impact factor: 2.778

View more
  37 in total

1.  Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation.

Authors:  Arafat Hussein Al-Dujaili; Hussein Kadhem Al-Hakeim; Ahmed Jasim Twayej; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-07-10       Impact factor: 3.584

2.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

3.  Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.

Authors:  P Laurant; A Berthelot
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 4.  The Effects of Magnesium Supplementation on Blood Pressure and Obesity Measure Among Type 2 Diabetes Patient: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Omid Asbaghi; Reza Hosseini; Behnoosh Boozari; Ehsan Ghaedi; Sara Kashkooli; Sajjad Moradi
Journal:  Biol Trace Elem Res       Date:  2020-05-08       Impact factor: 3.738

5.  Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism.

Authors:  Jun Sugimoto; Andrea M Romani; Alice M Valentin-Torres; Angel A Luciano; Christina M Ramirez Kitchen; Nicholas Funderburg; Sam Mesiano; Helene B Bernstein
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

6.  Magnesium and Hemorrhage Volume in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Eric M Liotta; Ameeta Karmarkar; Ayush Batra; Minjee Kim; Shyam Prabhakaran; Andrew M Naidech; Matthew B Maas
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

7.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

8.  Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats.

Authors:  Koji Yokoo; Risa Murakami; Takanobu Matsuzaki; Kanako Yoshitome; Akinobu Hamada; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2009-07-24       Impact factor: 2.801

9.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.

Authors:  W B Weglicki; I T Mak; R E Stafford; B F Dickens; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.